Allianz Asset Management Gmb H Vericel Corp Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $662,881 - $1.23 Million	-77,986 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$7.25 - $19.22 $2.39 Million - $6.34 Million	-329,764 Reduced 80.87%	77,986 $715,000
Q4 2019 Feb 13, 2020	BUY	$13.77 - $19.2 $725,197 - $1.01 Million	52,665 Added 14.83%	407,750 $7.1 Million
Q3 2019 Nov 13, 2019	SELL	$14.93 - $19.83 $1.36 Million - $1.81 Million	-91,161 Reduced 20.43%	355,085 $5.38 Million
Q2 2019 Aug 08, 2019	BUY	$15.01 - $18.89 $3.22 Million - $4.06 Million	214,754 Added 92.77%	446,246 $8.43 Million
Q1 2019 May 13, 2019	SELL	$16.23 - $20.29 $76,037 - $95,058	-4,685 Reduced 1.98%	231,492 $4.05 Million
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $163,779 - $280,417	-15,207 Reduced 6.05%	236,177 $4.11 Million
Q3 2018 Nov 13, 2018	BUY	$9.1 - $14.8 $2.29 Million - $3.72 Million	251,384 New	251,384 $3.56 Million

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.